Polycystic ovary syndrome. Polycystic ovarian syndrome
Conditions
Interventions
Intervention 1: Control group: with Oral rehydration solutions(ORS) (Porsina, placebo, Iran) twice a day for 8 weeks. Intervention 2: Intervention group: receiving metformin (500 mg twice a day) for 8
Sponsors
Arak University
Eligibility
Sex/Gender
Female
Age
25 Years to 35 Years
Inclusion criteria
Inclusion criteria: Infertility due to polycystic ovary syndrome Patients with polycystic ovary syndrome aged 25 to 35
Exclusion criteria
Exclusion criteria: Patients with hypersensitivity to metformin Patients with hypersensitivity to dipeptidyl peptidase-4 inhibitors Patients with hypersensitivity to sodium glucose cotransporter-2 Male infertility Patients with congenital adrenal hyperplasia Patients with thyroid gland disorders Patients with Cushing's syndrome Patients with androgen secreting neoplasia Severe liver diseases Severe kidney diseases Patients with gallstones
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Investigation of changes in biochemical factors in blood serum. Timepoint: Measurement of biochemical factors before the patient started taking the drug and 8 weeks after taking the drug on the day of puncture. Method of measurement: Using the ELISA kit.;Investigation of changes in hormonal factors in blood serum. Timepoint: Measurement of hormonal factors before the patient started taking the drug and 8 weeks after taking the drug on the day of puncture. Method of measurement: Using the ELISA kit. | — |
Secondary
| Measure | Time frame |
|---|---|
| The number of eggs obtained. Timepoint: On the day of puncture, the patient's egg count is checked. Method of measurement: Oocyte collection by ultrasound-guided transvaginal aspiration using a single-lumen needle. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMahdieh Sadat Mousavi
Arak University
Outcome results
None listed